123 related articles for article (PubMed ID: 2145783)
1. Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesia.
Dresner DL; Basta SJ; Ali HH; Schwartz AF; Embree PB; Wargin WA; Lai AA; Brady KA; Savarese JJ
Anesth Analg; 1990 Nov; 71(5):498-502. PubMed ID: 2145783
[TBL] [Abstract][Full Text] [Related]
2. Influence of aging on the pharmacokinetics and pharmacodynamics of doxacurium.
Gariepy LP; Varin F; Donati F; Salib Y; Bevan DR
Clin Pharmacol Ther; 1993 Mar; 53(3):340-7. PubMed ID: 8453853
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of doxacurium in normal patients and in those with hepatic or renal failure.
Cook DR; Freeman JA; Lai AA; Robertson KA; Kang Y; Stiller RL; Aggarwal S; Abou-Donia MM; Welch RM
Anesth Analg; 1991 Feb; 72(2):145-50. PubMed ID: 1824669
[TBL] [Abstract][Full Text] [Related]
4. Dose-response relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patients.
Koscielniak-Nielsen ZJ; Law-Min JC; Donati F; Bevan DR; Clement P; Wise R
Anesth Analg; 1992 Jun; 74(6):845-50. PubMed ID: 1534472
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular effects of doxacurium chloride in isoflurane-anesthetized dogs.
Martinez EA; Wooldridge AA; Hartsfield SM; Mealey KL
Vet Surg; 1998; 27(3):279-83. PubMed ID: 9605239
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.
Basta SJ; Savarese JJ; Ali HH; Embree PB; Schwartz AF; Rudd GD; Wastila WB
Anesthesiology; 1988 Oct; 69(4):478-86. PubMed ID: 2972233
[TBL] [Abstract][Full Text] [Related]
7. The clinical pharmacology of doxacurium in young adults and in elderly patients.
Martlew RA; Harper NJ
Anaesthesia; 1995 Sep; 50(9):779-82. PubMed ID: 7573867
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane.
Goudsouzian NG; Alifimoff JK; Liu LM; Foster V; McNulty B; Savarese JJ
Br J Anaesth; 1989 Mar; 62(3):263-8. PubMed ID: 2522789
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.
Cashman JN; Luke JJ; Jones RM
Br J Anaesth; 1990 Feb; 64(2):186-92. PubMed ID: 2138489
[TBL] [Abstract][Full Text] [Related]
10. Neuromuscular and cardiovascular effects of mivacurium chloride (BW B109OU) during nitrous oxide-narcotic, nitrous oxide-halothane and nitrous oxide-isoflurane anesthesia in surgical patients.
Pearson KS; From RP; Choi WW; Abou-Donia M; Sokoll MD
Middle East J Anaesthesiol; 1990 Jun; 10(5):469-78. PubMed ID: 2146482
[TBL] [Abstract][Full Text] [Related]
11. The influence of renal function on the pharmacokinetics and pharmacodynamics and simulated time course of doxacurium.
Fisher DM; Reynolds KS; Schmith VD; Hsu J; Sokoll MD; Lennon RL; Caldwell JE
Anesth Analg; 1999 Sep; 89(3):786-95. PubMed ID: 10475326
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics and steady state pharmacodynamics of mivacurium in children.
Markakis DA; Lau M; Brown R; Luks AM; Sharma ML; Fisher DM
Anesthesiology; 1998 Apr; 88(4):978-83. PubMed ID: 9579507
[TBL] [Abstract][Full Text] [Related]
13. Doxacurium pharmacodynamics in children during volatile and opioid-based anaesthesia.
Kern C; Tassonyi E; Rouge JC; Wilder-Smith OH; Pittet JF
Anaesthesia; 1996 Apr; 51(4):361-4. PubMed ID: 8686826
[TBL] [Abstract][Full Text] [Related]
14. The neuromuscular blocking and cardiovascular effects of doxacurium chloride in patients receiving nitrous oxide narcotic anesthesia.
Murray DJ; Mehta MP; Choi WW; Forbes RB; Sokoll MD; Gergis SD; Rudd GD; Abou-Donia MM
Anesthesiology; 1988 Oct; 69(4):472-7. PubMed ID: 3177909
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular and cardiovascular effects of mivacurium chloride in surgical patients receiving nitrous oxide-narcotic or nitrous oxide-isoflurane anaesthesia.
Choi WW; Mehta MP; Murray DJ; Sokoll MD; Forbes RB; Gergis SD; Abou-Donia M; Kirchner J
Can J Anaesth; 1989 Nov; 36(6):641-50. PubMed ID: 2573436
[TBL] [Abstract][Full Text] [Related]
16. Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children.
Bevan JC; Purday JP; Reimer EJ; Bevan DR
Can J Anaesth; 1994 Nov; 41(11):1074-80. PubMed ID: 7828255
[TBL] [Abstract][Full Text] [Related]
17. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
Lien CA; Schmith VD; Embree PB; Belmont MR; Wargin WA; Savarese JJ
Anesthesiology; 1994 Jun; 80(6):1296-302. PubMed ID: 8010476
[TBL] [Abstract][Full Text] [Related]
19. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
Mirakhur RK
Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacodynamics of doxacurium.
Schmith VD; Fiedler-Kelly J; Abou-Donia M; Huffman CS; Grasela TH
Clin Pharmacol Ther; 1992 Nov; 52(5):528-36. PubMed ID: 1424427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
